Navigation Links
BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
Date:10/14/2008

-Funds to support creation of market incentives and facilitate new R&D collaborations-

WASHINGTON, Oct. 14 /PRNewswire-USNewswire/ -- BIO Ventures for Global Health (BVGH) today announced that the Bill & Melinda Gates Foundation has expanded its support of the organization, so it can further engage biotechnology industry innovation to create new medicines for infectious diseases of the developing world. The $7 million grant will help BVGH build the market case for biotechnology industry investment through market-based incentives and to create new opportunities for R&D collaborations.

"We are thrilled by the Bill & Melinda Gates Foundation's support for expanding the BVGH mission," said Christopher D. Earl, PhD, President and CEO of BVGH. "Biotechnology industry resources are integral to the discovery of new solutions for the millions of patients suffering from diseases such as malaria, tuberculosis and African sleeping sickness."

Barriers such as insufficient markets, funding, and information continue to deter industry from applying their technologies to research and development for neglected tropical diseases (NTDs). BVGH is tackling these barriers and addressing the issues most often identified by both the public and private sectors as limiting collaboration and the application of biotechnology resources.

"The biotech industry has an exceptional opportunity to apply its innovative skills to create new global health solutions," said Tachi Yamada, MD, President of the Gates Foundation's Global Health Program. "BVGH designs economic incentives and partnerships that help make this industry commitment possible."

BVGH's accomplishments are measured by the growing numbers of companies who are committing their best scientists and technologies to solving the most pressing public health needs across the globe.

"Improving health care in developing nations is a goal that all biotechnology companies share," said Joshua Boger, Ph
'/>"/>

SOURCE BIO Ventures for Global Health
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Hank Plain Joins Morgenthaler Ventures as Partner
2. Dan Broderick Joins Prolog Ventures as Partner
3. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
4. Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
5. Khosla Ventures and BIOeCON Form KiOR Inc.
6. Jerusalem Global Ventures Announces $200 Million Growth Equity Fund
7. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
8. Clarus Ventures Closes $660 Million Fund
9. The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
10. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
11. SPO Medical Retains American Capital Ventures for Investor Relations Services

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... 9 For more than 20 years,research...velopment of a,Brain-Computer Interface (BCI). Thi...ain and a computer. Such a system enables complete... devices in their environment just by,mental activ... supervised by,the researchers themselves to use s...
(Date:11/9/2009)...e is a research industry first, allowing veterinar...rch safety study data to be managed in one softwar...olls, NJ (PRWEB) November 9, 2009 -- Xybion Medica...stima™ VM, an integrated enterprise software...se and care of veterinary research subjects. Prist...
(Date:11/6/2009)...all/ - Microbix Biosystems Inc. (the "Company") an...F1 Certification of Annual Filings of William Gast...e Chief Financial Officer (the "Officer,s Certific...he annual audited financial statements for the yea...ially filed the annual financial statements for th...
(Date:11/6/2009)...ire-FirstCall/ -- ,, 3Q09 Corporate Highligh.... Marketing Authorization to Astellas Pharma Europ...eadiness activities Expanded management team to i...irector, Commercial Operations Appointed Bradford...ee chairman , Upcoming 2009 Milestones: ,...
Breaking Biology Technology:intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10
...n Scheduled for Wednesday, May 7th at 9:30am EDT, ...asdaq: KERX ) today announced that Michael S. Wei...icer, is scheduled to present at the,Deutsche Bank...sachusetts., Mr. Weiss, presentation, which will ...ll be webcast live and will be accessible from the...
...y 5 /PRNewswire-FirstCall/ - Lorus Therapeutics In...tical company dedicated in,the research, developme...s,and technologies for the management of cancer, a... management team with the appointment of Dr. Saeid...and Dr. Yoon Lee to,Vice-President of Research. Bo...
...RANCISCO, Calif., May 5 VaxGen,Inc. (OTC Bulletin...ounced,today it has completed the sale of all asse...e antigen (rPA) anthrax vaccine product candidate ...nc. Under the terms of the,transaction, Emergent B...of,the definitive agreement and may be obligated t...
Other Biology Technology:Keryx Biopharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference 2Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions 2Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions 3Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions 4VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc. 2
(Date:11/6/2009)...s generally live in harmony with their arboreal ho...out of space in their trees of choice, the ants ca...search, published in the November issue of the Am...ants bore into live trees, and it reopens a centur...d plants. , Ants and certain species of plants a...
(Date:11/5/2009)...esearchers at Yale University have developed synth...une response to HIV and HIV-infected cells, as wel...lished online in the Journal of the American Chem...roaches for these diseases. , The molecules ca...(ARM-H) and "antibody-recruiting molecule targetin...
(Date:11/4/2009)...ridors in the cities of Long Beach and Riverside a...ventable childhood asthma, and the true impact of ...s likely been underestimated, according to researc...). , The study, which appears in an online edit...timated that nine percent of all childhood asthma ...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2New synthetic molecules trigger immune response to HIV and prostate cancer 2USC study finds big air pollution impacts on local communities 2Sinovac Schedules 2008 Annual General Meeting 48447 1Sinovac Schedules 2008 Annual General Meeting 48447 2The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 1The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 2The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 3American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 1American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 2American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 3American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 4
...ly of their own, members of some bird species will...r young. Now, researchers report evidence that in ...ost common among species that live in savannas, wh...possible to predict. The findings appear online Au...ion of Cell Press. , When the unpredictability of...
...ng hormone in African Americans known to potential...D., the senior author of a study in the September ...ciate professor of kinesiology at Temple Universit...aldosterone, influences the kidneys regulation of ...to the development of hypertension because it caus...
... new disease problems, a far more cost effective a...ate in the places where they often commingle: in w... to wildlife health experts from the Wildlife Cons... and Agriculture Organization (FAO) in a recent is...s. , This is an ounce of prevention that we reall...
Other Biology News:Uncertainty drives the evolution of 'cooperative breeding' in birds 2Understanding hypertension in African Americans proves elusive 2Emerging (disease) markets 2
Anti-Ezrin / Radixin / Moesin Antibody, Unconjugated from CHEMICON
Rat Anti-Mouse ABCA1 Monoclonal Antibody, Unconjugated, Clone 5A1-1422.11 from ABR-Affinity BioReagents
Goat Anti-Human SART3 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Hamartin Monoclonal Antibody, Unconjugated, Clone 1B2 from Cell Signaling Technology
Biology Products: